HomeANAB • NASDAQ
add
AnaptysBio Inc
Previous close
$55.41
Day range
$55.28 - $59.88
Year range
$15.32 - $63.47
Market cap
1.72B USD
Avg Volume
460.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 108.25M | 151.08% |
Operating expense | 15.79M | 54.89% |
Net income | 49.61M | 327.75% |
Net profit margin | 45.83 | 190.70% |
Earnings per share | 1.58 | 319.44% |
EBITDA | 67.03M | 803.75% |
Effective tax rate | 0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 311.64M | -19.13% |
Total assets | 364.40M | -24.69% |
Total liabilities | 327.18M | -20.77% |
Total equity | 37.21M | — |
Shares outstanding | 28.75M | — |
Price to book | 41.66 | — |
Return on assets | 46.62% | — |
Return on capital | 51.87% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 49.61M | 327.75% |
Cash from operations | 98.00M | 246.98% |
Cash from investing | 73.50M | 350.03% |
Cash from financing | -43.13M | -256.47% |
Net change in cash | 128.36M | 287.39% |
Free cash flow | 82.17M | 335.92% |
About
Founded
2005
Headquarters
Website
Employees
104
